Endurant Capital Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-15,110
| Closed | -$481K | – | 47 |
|
|
2023
Q3 | $481K | Sell |
15,110
-7,761
| -34% | -$247K | 0.43% | 40 |
|
|
2023
Q2 | $768K | Sell |
22,871
-49,340
| -68% | -$1.66M | 0.67% | 23 |
|
|
2023
Q1 | $3.01M | Sell |
72,211
-53,710
| -43% | -$2.24M | 1.55% | 17 |
|
|
2022
Q4 | $4.27M | Sell |
125,921
-5,359
| -4% | -$182K | 1.73% | 16 |
|
|
2022
Q3 | $6.46M | Sell |
131,280
-22,441
| -15% | -$1.1M | 2.1% | 19 |
|
|
2022
Q2 | $6.04M | Buy |
153,721
+38,656
| +34% | +$1.52M | 2.12% | 14 |
|
|
2022
Q1 | $4.25M | Buy |
115,065
+44,281
| +63% | +$1.63M | 1.12% | 23 |
|
|
2021
Q4 | $6.92M | Buy |
70,784
+36,734
| +108% | +$3.59M | 1.67% | 18 |
|
|
2021
Q3 | $4.25M | Buy |
34,050
+3,152
| +10% | +$393K | 0.97% | 26 |
|
|
2021
Q2 | $3.88M | Buy |
30,898
+508
| +2% | +$63.7K | 1.07% | 36 |
|
|
2021
Q1 | $4.13M | Sell |
30,390
-2,629
| -8% | -$357K | 1.08% | 34 |
|
|
2020
Q4 | $3M | Sell |
33,019
-17,383
| -34% | -$1.58M | 1.08% | 32 |
|
|
2020
Q3 | $3.75M | Sell |
50,402
-8,909
| -15% | -$663K | 1.11% | 27 |
|
|
2020
Q2 | $5.05M | Buy |
59,311
+50,801
| +597% | +$4.33M | 0.28% | 20 |
|
|
2020
Q1 | $615K | Buy |
8,510
+7,650
| +890% | +$553K | 0.28% | 41 |
|
|
2019
Q4 | $61K | Buy |
+860
| New | +$61K | 0.02% | 51 |
|